Some individuals notice subtle changes as early as day 4 to 5, while others require 3 to 4 weeks for meaningful effects
222 Although limited direct evidence has evaluated use of GLP-1s with or without RDN-provided MNT, the SCALE, 13 STEP 1, 14 SURMOUNT, 15 and STEP 3 178 trials each demonstrated substantial weight reduction by combining GLP-1s with regular counseling sessions by RDNs or other qualified healthcare professionals (such lifestyle support was also provided to the placebo group in each trial)
Similarly, BPC-157 supports your bodys cells as they regenerate, with progressive improvement over time
Originally approved for people with type 2 diabetes, several GLP-1 receptor agonists now have FDA indications for weight management, including once-weekly injectable semaglutide 2.4 mg (Wegovy, Novo Nordisk) and tirzepatide (Zepbound, Eli Lilly), an injectable GIP/GLP-1 dual incretin-based agonist